Shuttle Pharmaceuticals Holdings, Inc.

As of June 20, 2025, the market trend is neutral with mixed signals, as weekly indicators show mild bullishness while daily moving averages and the RSI suggest potential weakness, leading to indecisiveness overall.

Shuttle Pharmaceuticals Holdings, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $3.62 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -273.64%.

As of Jun 18, Shuttle Pharmaceuticals Holdings, Inc. has a market capitalization of 3.62 million, with net sales of 0.00 million and a net profit of -10.46 million over the latest four quarters. The company reported shareholder's funds of 0.71 million and total assets of 2.51 million as of Dec 24.